Latest news with #AartiPharmalabs
Business Standard
12-05-2025
- Business
- Business Standard
Aarti Pharmalabs Q4 PAT climbs 35% YoY to Rs 88 cr
Aarti Pharmalabs reported 35.38% increase in consolidated net profit to Rs 88.34 crore in Q4 FY25 as against Rs 65.25 crore posted in Q4 FY24. Revenue from operations jumped 11.46% YoY to Rs 563.78 crore in the quarter ended 31 March 2025. Profit before tax was at Rs 114.62 crore in the fourth quarter of FY25, up 19.70% from Rs 95.75 crore posted in the same period a year ago. Total expenses increased 8.61% to Rs 447.55 crore in Q4 FY25, compared to Rs 412.05 crore reported in Q4 FY24. The cost of material consumed stood at Rs 185.45 crore (down 7.97% YoY), employee benefit expenses were at Rs 43.37 crore (up 43.37% YoY) and finance costs stood at Rs 6.58 crore (up 40.59% YoY) during the period under review. On a full-year basis, the companys net profit rose 25.58% to Rs 272.40 crore on a 14.16% increase in revenue to Rs 2,115.07 crore in FY25 over FY24. The company's board has recommended a dividend of Rs 2.5 per equity share for the financial year 2024-25. Subject to the approval of the shareholders at the ensuing annual general meeting of the company. Aarti Pharmalabs (APL) is an established, internationally recognized manufacturer of active pharmaceutical ingredients (API), pharmaceutical intermediates, new chemical entities (NCE), and xanthine derivatives situated in India. The counter declined 1.33% to Rs 757.15 on the BSE.
Business Standard
12-05-2025
- Business
- Business Standard
Aarti Pharmalabs consolidated net profit rises 35.39% in the March 2025 quarter
Sales rise 11.47% to Rs 563.78 crore Net profit of Aarti Pharmalabs rose 35.39% to Rs 88.34 crore in the quarter ended March 2025 as against Rs 65.25 crore during the previous quarter ended March 2024. Sales rose 11.47% to Rs 563.78 crore in the quarter ended March 2025 as against Rs 505.77 crore during the previous quarter ended March 2024. For the full year,net profit rose 25.59% to Rs 272.40 crore in the year ended March 2025 as against Rs 216.90 crore during the previous year ended March 2024. Sales rose 14.17% to Rs 2115.07 crore in the year ended March 2025 as against Rs 1852.61 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 563.78505.77 11 2115.071852.61 14 OPM % 25.8323.24 - 21.9620.84 - PBDT 137.44114.87 20 447.59373.73 20 PBT 114.6295.75 20 360.69300.49 20 NP 88.3465.25 35 272.40216.90 26
